Tempest Therapeutics announced it raised $4.06 Million in an initial filing from an offering of $4.06 Million
PUBLIC · TPSTJun 23, 2026
Amount Raised
$4.06 Million
Round Type
Seed
San FranciscoBiotechnologyHealthcareHealth CareTherapeuticsBiopharma
Investors
H.C. Wainwright & Co.
Description
Tempest Therapeutics has entered into definitive agreements for a private placement of 3,105,591 shares of common stock at $0.805 per share, raising approximately $2.5 million in gross proceeds. The offering also includes series C and D warrants that could generate up to $5 million in additional capital if fully exercised. H.C. Wainwright & Co
Company Information
Company
Tempest Therapeutics
Location
ONE SANSOME STREET
San Francisco, California, United States
About
Tempest Therapeutics is a development-stage biotechnology company.
Fundz sees it the moment Tempest Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.